Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 study

Acquired hemophilia A (AHA) is due to autoantibodies against coagulation factor VIII (FVIII) and most often presents with unexpected bleeding. In contrast to congenital hemophilia, the patient’s residual FVIII activity does not seem to correlate with the risk of bleeding as suggested from previous s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Holstein, Katharina, Liu, Xiaofei, Smith, Andrea, Knöbl, Paul, Klamroth, Robert, Geisen, Ulrich, Eichler, Hermann, Miesbach, Wolfgang, Tiede, Andreas
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2020
Materias:
Clinical Trials and Observations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7392842/
https://ncbi.nlm.nih.gov/pubmed/32268359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019003639
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares